Novo Nordisk prepares to go global as triple-G prospect passes midphase diabetes test in China Read more 

BrightGene's oral dual agonist sees up to 8% weight loss at 8 weeks in slice of early data Read more 

Icon, Advarra partnership aims to optimize trials, expand access Read more 

Max Eldridge

Max has more than ten years in Life Sciences recruitment, He collaborates with executives to foster growth in Pharma, Biotech, CRO, TechBio, and Medical Device sectors​

Go to Top